Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Oak vs VitaFusions IV

Oak
Graded #42

Higher grade

vs+13.800000000000004
VitaFusions IV
Graded #279

Lower grade

The verdict

Oak takes it — 75.9/100 to 62.1/100.

Oak grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The cheapest published prices on the board, sold as a package with no membership fee.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOak +38
96
58
Dose & formulationVitaFusions IV +10
62
72
Clinical oversightVitaFusions IV +8
66
74
Labs & monitoringOak +5
58
53
FulfillmentOak +26
88
62
Contract termsOak +51
88
37
Oak · left barVitaFusions IV · right bar

The numbers

MetricOakVitaFusions IV
WeighScore75.9/10062.1/100
GradeCC
Scorecard rank#42#279
SemaglutideFrom $119/mo$149/mo (all doses, plus a separate fee, compounded)
TirzepatideFrom $185/mo$189/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Oak

Graded #42 · C

Strengths

  • Lowest published prices here — semaglutide from $119/mo, tirzepatide from $185/mo
  • One price across every dosage, so titrating up costs no more
  • No membership or subscription fee, and free shipping
  • All 50 states, offered in Spanish as well as English

Where it loses points

  • Same-day approval with no video call means very little clinical contact before a prescription
  • No published lab or monitoring programme
  • Injection only, and no brand-name lane
  • Sold as packages, so re-ordering is on you
VitaFusions IV

Graded #279 · C

Strengths

  • Semaglutide confirmed from page metadata
  • Published flat package pricing: semaglutide from $149, tirzepatide $189 for a 7-week supply, no insurance/memberships/contracts

Where it loses points

  • Advertised prices are 7-week package prices, not monthly; homepage banner ('$199 for 7 weeks') conflicts with the program page ('Starting $149')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard